Developer docs
API playgroundTry for free, no card

Search company profiles

ION

Full company profile

uuid000s7g5

Namestring
ION
Legal namestring
Cencora, Inc.
Websiteurl
iononline.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

ION Oncology Practice Network is a division of Cencora, Inc. (formerly AmerisourceBergen) that operates as the longest-standing oncology-specific Group Purchasing Organization (GPO) and physician services organization in the United States. Founded over 20 years ago and now embedded within a Fortune 20 parent, ION serves community oncology practices by aggregating purchasing power across 5,000+ physicians, providing access to 150+ pharmaceutical contracts, and supplying practice operations, clinical, and reimbursement support. Its core products include the ION GPO membership, a suite of proprietary software modules (InfoDive for practice business analytics, Protocol Analyzer for drug and treatment cost analysis, IntelliDoseTxM for infusion management, AdvanceIQ Network for clinical trial recruitment, the SmartRx Suite for pharmacy/dispensing operations, and GPOconnect for membership performance tracking), MIPS consulting services, and the medically integrated dispensing (MID) program.

The technology architecture is a multi-module platform that integrates with practice EHR, PM, and inventory systems, digitizes NCCN clinical protocols through electronic connections, and uses proprietary analytics to surface operational and revenue insights. SmartRx Analyzer feeds into a combined Practice Health Insights application that unifies pharmacy, clinical, and financial data. Revenue is generated through recurring GPO membership fees (subscription), medically integrated dispensing managed services, MIPS and practice consulting engagements (professional services), and software subscriptions. Go-to-market is sales-led and relationship-driven: direct sales to community oncology practices, content-led demand generation through webinars, publications, the OnCall podcast, and industry events, with strategic distribution partnerships including Prime Therapeutics (IntegratedRx-Oncology), NCODA, the Oncology Optimized Limited Distribution Model, and Blue Cross and Blue Shield Plans.

Short descriptiontext

ION Oncology Practice Network, a division of Cencora (formerly AmerisourceBergen), is the longest-standing U.S. oncology-specific GPO and physician services organization, serving 5,000+ community oncology physicians with pharmaceutical contracts, practice analytics software, infusion and dispensing tools, and consulting services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersConshohocken, United States
HQ citystring
Conshohocken
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology GPO services, physician practice services, medically integrated dispensing, pharmacy benefit management, clinical research network
Industry2 codes
1Medical Oncology
CodeHLAKAFABPrimaryYes
2Clinical Trial Monitoring Support (On-site/Remote)
CodeHLAGACAGPrimaryNo
NAICS code2 codes
  • Offices of Physicians62111
  • Other Scientific and Technical Consulting Services54169
SIC code3 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
  • Services-Management Consulting Services8742
Product category
Healthcare GPO and Physician Services
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1GPO Membership Fees
TypeSubscription Recurring
Description

ION operates as an oncology-specific GPO providing member practices access to pharmaceutical contracts at competitive rates. The GPO model aggregates purchasing power across member practices.

iononline.com
2Medically Integrated Dispensing Services
TypeManaged Services
Description

Supporting practices in implementing and operating medically integrated dispensing programs. Services include pharmacy setup, workflow optimization, and dispensing software solutions.

iononline.com
3MIPS Consulting Services
TypeProfessional Services
Description

Consulting services helping practices navigate MIPS reporting requirements, optimize quality metrics, and secure upward payment adjustments while avoiding penalties.

iononline.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ION Oncology Practice Network is a community oncology-specific Group Purchasing Organization (GPO) and physician service organization that aggregates purchasing power across independent oncology practices to deliver competitive pharmaceutical contracts, practice analytics software, medically integrated dispensing services, MIPS consulting, and clinical trial access. It also sells proprietary software modules (InfoDive, Protocol Analyzer, IntelliDoseTxM, SmartRx suite, GPOconnect) and provides consulting and educational content to support clinical, operational, and financial workflows of community oncology practices.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • $72.76M+ in penalties avoided for MIPS clients (2020-2023)
+6 more records
Product overview1 text field

ION Oncology Practice Network is a comprehensive oncology-specific GPO and physician service organization that operates as a multi-module platform for community oncology practices. The core offering combines GPO membership with contracted pharmaceutical access (150+ contracts), supported by integrated software modules including InfoDive for business analytics, Protocol Analyzer for treatment cost analysis, and SmartRx suite (Reconciliation, Fill, Analyzer, Credentialing) for dispensing operations. The platform also includes IntelliDoseTxM for infusion management with EMR integration, AdvanceIQ Network for clinical trial recruitment, MIPS Consulting Services for value-based care reporting, and GPIN for market research participation. Educational resources are provided through OnDemand and OnCall podcast, enabling over 5,000 physicians with comprehensive practice support across clinical, operational, and financial dimensions.

Product and service1 record
1ION Oncology Practice Network (GPO Membership)
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

NCODA publishes and tracks value demonstration metrics for medically integrated dispensing models including adherence, access, affordability, time to fill, education, patient satisfaction, and cost avoidance. The organization supports MID practices through standards and advocacy.

2Oncology Optimized Limited Distribution (OOLD) Model
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Excludes PBM-affiliated mail order pharmacies from limited distribution networks, enabling MID practices to capture a higher percentage of drug fills. As of April 2026, 44 unique drugs had adopted this model with MID practices capturing 89% of fills.

iononline.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Partnership with Prime Therapeutics offers IntegratedRx-Oncology, a clinically integrated dispensing program allowing patients to receive oral oncolytics in a community oncology setting. The program enables real-time data sharing, waste reduction, and coordinated care between dispensing pharmacists and clinical teams. Prime Therapeutics provides pharmacy benefit management and clinical integration while AmerisourceBergen provides PSAO services and practice network access.

Strategic tierCoreTypeTechnology or Integration
Description

NCCN provides clinical practice guidelines and protocols used in IntelliDoseTxM infusion management system. The digitized NCCN protocols are integrated through electronic connection, allowing seamless updates in practice workflows.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Non-profit foundation addressing cancer care disparities through patient assistance, screening programs, and financial support. Dr. Kashyap Patel founded NOLA to eliminate disparities in cancer care access.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

IntegratedRx-Oncology model is currently available to community oncology physicians and health systems participating in Blue Cross plans. Practices must achieve accreditation within one year.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

McKesson-owned physician services organization supporting community oncology practices with practice management, drug purchasing, and technology. Most direct competitor given aligned community oncology focus, comparable GPO offering, and similar physician practice affiliation model.

TypeDirect peer
Description

Aggregator platform partnering with independent community oncology practices to negotiate payer contracts, manage drug purchasing, and provide technology. Competes with ION for the same independent oncology practice segment and offers an alternative affiliation model.

TypeBroad incumbent
Description

Major pharmaceutical distributor with specialty solutions including GPO services and practice support in oncology. Competes broadly with ION via distribution leverage and offers overlapping services like Innovative Practice Solutions for community oncology.

TypeBroad incumbent
Description

Parent of US Oncology Network and one of the largest pharmaceutical distributors in the US. Cencora's primary competitor in distribution, with parallel physician services offerings and GPO scale that overlap ION's service area.

TypeBroad incumbent
Description

Large healthcare GPO offering group purchasing, supply chain, and performance services. Broader than ION (not oncology-specific) but competes for the same healthcare purchasing aggregate spend and provides similar benchmarking and analytics tooling.

TypeBroad incumbent
Description

Healthcare GPO and performance improvement company serving hospitals, health systems, and ambulatory providers. Competes with ION in the broader GPO + analytics space, though Vizient is more acute-care-anchored than community oncology.

TypeBroad incumbent
Description

GPO serving acute care providers with pharmaceutical and supply contracts plus performance services. A broader GPO peer with similar membership-based pricing model and contract aggregation thesis as ION's 150+ pharma contracts.

8National Cancer Care Alliance
TypeDirect peer
Description

Network of independent community oncology practices pursuing collective value-based care contracting and practice collaboration. Direct competitor seeking to organize community oncology similarly to how ION's GPO members collaborate.

TypeEmerging player
Description

Specialty pharmacy integrator helping health systems build in-house specialty pharmacy programs. Adjacent competitor to ION's Medically Integrated Dispensing model, focused on health system rather than community practice delivery.

10NCODA
TypeOthers
Description

National Community Oncology Dispensing Association that publishes standards and metrics for medically integrated dispensing practices. Strategic alliance partner rather than direct competitor, but plays an adjacent ecosystem role that influences ION's MID customer relationships.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ION

Healthcare GPO and Physician Servicesiononline.com

ION Oncology Practice Network, a division of Cencora (formerly AmerisourceBergen), is the longest-standing U.S. oncology-specific GPO and physician services organization, serving 5,000+ community oncology physicians with pharmaceutical contracts, practice analytics software, infusion and dispensing tools, and consulting services.

What ION does

ION Oncology Practice Network is a division of Cencora, Inc. (formerly AmerisourceBergen) that operates as the longest-standing oncology-specific Group Purchasing Organization (GPO) and physician services organization in the United States. Founded over 20 years ago and now embedded within a Fortune 20 parent, ION serves community oncology practices by aggregating purchasing power across 5,000+ physicians, providing access to 150+ pharmaceutical contracts, and supplying practice operations, clinical, and reimbursement support. Its core products include the ION GPO membership, a suite of proprietary software modules (InfoDive for practice business analytics, Protocol Analyzer for drug and treatment cost analysis, IntelliDoseTxM for infusion management, AdvanceIQ Network for clinical trial recruitment, the SmartRx Suite for pharmacy/dispensing operations, and GPOconnect for membership performance tracking), MIPS consulting services, and the medically integrated dispensing (MID) program.

The technology architecture is a multi-module platform that integrates with practice EHR, PM, and inventory systems, digitizes NCCN clinical protocols through electronic connections, and uses proprietary analytics to surface operational and revenue insights. SmartRx Analyzer feeds into a combined Practice Health Insights application that unifies pharmacy, clinical, and financial data. Revenue is generated through recurring GPO membership fees (subscription), medically integrated dispensing managed services, MIPS and practice consulting engagements (professional services), and software subscriptions. Go-to-market is sales-led and relationship-driven: direct sales to community oncology practices, content-led demand generation through webinars, publications, the OnCall podcast, and industry events, with strategic distribution partnerships including Prime Therapeutics (IntegratedRx-Oncology), NCODA, the Oncology Optimized Limited Distribution Model, and Blue Cross and Blue Shield Plans.

ION firmographics

Firmographics
Name
ION
Legal name
Cencora, Inc.
Website
https://iononline.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
501–1,000 employees
Short description
ION Oncology Practice Network, a division of Cencora (formerly AmerisourceBergen), is the longest-standing U.S. oncology-specific GPO and physician services organization, serving 5,000+ community oncology physicians with pharmaceutical contracts, practice analytics software, infusion and dispensing tools, and consulting services.
Ownership category
akta.pro rank

ION industry classification

Industry
Product category
Healthcare GPO and Physician Services
NAICS
Offices of Physicians (62111), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Services-Management Consulting Services (8742)
akta.pro primary industry
Medical Oncology (HLAKAFAB)
akta.pro secondary industry
Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

  • Oncology GPO services
  • Physician practice services
  • Medically integrated dispensing
  • Pharmacy benefit management
  • Clinical research network

Where ION is headquartered

Location

Headquarters

HQ city
Conshohocken
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ION business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. GPO Membership Fees: ION operates as an oncology-specific GPO providing member practices access to pharmaceutical contracts at competitive rates. The GPO model aggregates purchasing power across member practices.
  2. Medically Integrated Dispensing Services: Supporting practices in implementing and operating medically integrated dispensing programs. Services include pharmacy setup, workflow optimization, and dispensing software solutions.
  3. MIPS Consulting Services: Consulting services helping practices navigate MIPS reporting requirements, optimize quality metrics, and secure upward payment adjustments while avoiding penalties.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

ION product offering

Product offering

Core offering

ION Oncology Practice Network is a community oncology-specific Group Purchasing Organization (GPO) and physician service organization that aggregates purchasing power across independent oncology practices to deliver competitive pharmaceutical contracts, practice analytics software, medically integrated dispensing services, MIPS consulting, and clinical trial access. It also sells proprietary software modules (InfoDive, Protocol Analyzer, IntelliDoseTxM, SmartRx suite, GPOconnect) and provides consulting and educational content to support clinical, operational, and financial workflows of community oncology practices.

Product overview

ION Oncology Practice Network is a comprehensive oncology-specific GPO and physician service organization that operates as a multi-module platform for community oncology practices. The core offering combines GPO membership with contracted pharmaceutical access (150+ contracts), supported by integrated software modules including InfoDive for business analytics, Protocol Analyzer for treatment cost analysis, and SmartRx suite (Reconciliation, Fill, Analyzer, Credentialing) for dispensing operations. The platform also includes IntelliDoseTxM for infusion management with EMR integration, AdvanceIQ Network for clinical trial recruitment, MIPS Consulting Services for value-based care reporting, and GPIN for market research participation. Educational resources are provided through OnDemand and OnCall podcast, enabling over 5,000 physicians with comprehensive practice support across clinical, operational, and financial dimensions.

Differentiator

Problem solved

Functional benefit

Products and services

  • ION Oncology Practice Network (GPO Membership)

Quantifiable outcome

  • $72.76M+ in penalties avoided for MIPS clients (2020-2023)
  • +6 more outcomes

Companies that use ION

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

ION technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature6 records

ION partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • NCODA (National Community Oncology Dispensing Association)coreStrategic or Co-development Partner · 1 January 2023NCODA publishes and tracks value demonstration metrics for medically integrated dispensing models including adherence, access, affordability, time to fill, education, patient satisfaction, and cost avoidance. The organization supports MID practices through standards and advocacy.
  • Oncology Optimized Limited Distribution (OOLD) ModelcoreStrategic or Co-development Partner · 1 January 2023Excludes PBM-affiliated mail order pharmacies from limited distribution networks, enabling MID practices to capture a higher percentage of drug fills. As of April 2026, 44 unique drugs had adopted this model with MID practices capturing 89% of fills.
  • Prime Therapeutics - IntegratedRx-OncologycoreStrategic or Co-development Partner · 1 January 2021Partnership with Prime Therapeutics offers IntegratedRx-Oncology, a clinically integrated dispensing program allowing patients to receive oral oncolytics in a community oncology setting. The program enables real-time data sharing, waste reduction, and coordinated care between dispensing pharmacists and clinical teams. Prime Therapeutics provides pharmacy benefit management and clinical integration while AmerisourceBergen provides PSAO services and practice network access.
  • NCCN (National Comprehensive Cancer Network)coreTechnology or IntegrationNCCN provides clinical practice guidelines and protocols used in IntelliDoseTxM infusion management system. The digitized NCCN protocols are integrated through electronic connection, allowing seamless updates in practice workflows.
  • No One Left Alone (NOLA)minorStrategic or Co-development PartnerNon-profit foundation addressing cancer care disparities through patient assistance, screening programs, and financial support. Dr. Kashyap Patel founded NOLA to eliminate disparities in cancer care access.
  • Blue Cross and Blue Shield PlanscoreChannel Partner/ Reseller/ DistributorIntegratedRx-Oncology model is currently available to community oncology physicians and health systems participating in Blue Cross plans. Practices must achieve accreditation within one year.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

ION competitors and assessment

Company assessment

Direct peers

  • US Oncology Network (McKesson): McKesson-owned physician services organization supporting community oncology practices with practice management, drug purchasing, and technology. Most direct competitor given aligned community oncology focus, comparable GPO offering, and similar physician practice affiliation model.
  • OneOncology: Aggregator platform partnering with independent community oncology practices to negotiate payer contracts, manage drug purchasing, and provide technology. Competes with ION for the same independent oncology practice segment and offers an alternative affiliation model.
  • National Cancer Care Alliance: Network of independent community oncology practices pursuing collective value-based care contracting and practice collaboration. Direct competitor seeking to organize community oncology similarly to how ION's GPO members collaborate.

Broad incumbents

  • Cardinal Health Specialty Solutions: Major pharmaceutical distributor with specialty solutions including GPO services and practice support in oncology. Competes broadly with ION via distribution leverage and offers overlapping services like Innovative Practice Solutions for community oncology.
  • McKesson Corporation: Parent of US Oncology Network and one of the largest pharmaceutical distributors in the US. Cencora's primary competitor in distribution, with parallel physician services offerings and GPO scale that overlap ION's service area.
  • Premier Inc: Large healthcare GPO offering group purchasing, supply chain, and performance services. Broader than ION (not oncology-specific) but competes for the same healthcare purchasing aggregate spend and provides similar benchmarking and analytics tooling.
  • Vizient: Healthcare GPO and performance improvement company serving hospitals, health systems, and ambulatory providers. Competes with ION in the broader GPO + analytics space, though Vizient is more acute-care-anchored than community oncology.
  • HealthTrust (HCA): GPO serving acute care providers with pharmaceutical and supply contracts plus performance services. A broader GPO peer with similar membership-based pricing model and contract aggregation thesis as ION's 150+ pharma contracts.

Emerging players

  • Shields Health Solutions: Specialty pharmacy integrator helping health systems build in-house specialty pharmacy programs. Adjacent competitor to ION's Medically Integrated Dispensing model, focused on health system rather than community practice delivery.

Others

  • NCODA: National Community Oncology Dispensing Association that publishes standards and metrics for medically integrated dispensing practices. Strategic alliance partner rather than direct competitor, but plays an adjacent ecosystem role that influences ION's MID customer relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

ION social profiles

Digital presence

ION financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ION leadership team

Management profile

Number of profiles

Profiles2 records

ION funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ION M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ION

What does ION do?

ION Oncology Practice Network is a community oncology-specific Group Purchasing Organization (GPO) and physician service organization that aggregates purchasing power across independent oncology practices to deliver competitive pharmaceutical contracts, practice analytics software, medically integrated dispensing services, MIPS consulting, and clinical trial access. It also sells proprietary software modules (InfoDive, Protocol Analyzer, IntelliDoseTxM, SmartRx suite, GPOconnect) and provides consulting and educational content to support clinical, operational, and financial workflows of community oncology practices.

Is ION a public or private company?

ION is a private company. It is classified as corporate owned and is currently operating.

When was ION founded?

ION was founded in 2023. It employs 501 to 1,000 people.

Where is ION based?

ION is headquartered in Conshohocken, United States, in the North America region.

How does ION make money?

Three revenue lines are on record. GPO Membership Fees are the primary driver. The others are medically Integrated Dispensing Services and MIPS Consulting Services.

Who are ION's main competitors?

Direct peers on record are US Oncology Network (McKesson), OneOncology and National Cancer Care Alliance. Broad incumbents are Cardinal Health Specialty Solutions, McKesson Corporation, Premier Inc, Vizient and HealthTrust (HCA). Shields Health Solutions is listed as an emerging player. NCODA is listed as an others.

Does ION have an API?

No public API is recorded for ION.

What industry is ION in?

ION's product category is Healthcare GPO and Physician Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote). Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooWhy the WNBA’s new TV deal is the biggest bargain in sports broadcastingThe WNBA has secured new media rights agreements totaling $3.1 billion over 10 years ($281 million annually), with deals from Disney/ABC/ESPN, Comcast/NBC/Peacock, Paramount/CBS, Scripps/Ion, Versant/USA, and Bell Media/TSN covering 245 nationally broadcast games this season. The article argues the deal represents a bargain for rights holders given the WNBA's strong viewership averaging 1.2 million viewers per game, outpacing the NHL's 760,000 average, despite charging only $1.15 million per game compared to the NHL's $2.32 million. The league includes a three-year adjustment option to revisit deal values as new expansion teams Toronto Tempo and Portland Fire join the league and growth continues.Stock TitanScripps Q4 revenue hits $560M, posts $44.9M lossE.W. Scripps Company reported Q4 2025 revenue of $560 million but posted a net loss of $44.9 million (51 cents per share), compared to income of $80.3 million in the prior-year quarter, as political advertising revenue collapsed to $9 million from $174 million in the election-year quarter. The company announced a transformation plan targeting $125-$150 million in annualized EBITDA growth by 2028 through cost savings and revenue initiatives leveraging AI and automation, with early benefits expected in the second half of 2026. Scripps also revealed plans to re-acquire 23 ION-affiliated stations for approximately $54 million, sell two affiliate stations for $123 million, and execute a station swap with Gray Media across five markets.Sports Media WatchSports Ratings TrackerThe article reports on recent sports ratings for NBA and WNBA games, including viewership data for games broadcast on ESPN, ABC, CBS, and ION. The report highlights changes in viewership figures from last year and demographic shifts, particularly noting the impact of notable players' absences.FinancialContent Business PageCAH Q3 Deep Dive: Specialty Expansion, M&A Drive Strong Top-Line GrowthCardinal Health reported Q3 CY2025 results with revenue of $64.01 billion, up 22.4% year-on-year and beating analyst estimates by 7.8%, while non-GAAP EPS of $2.55 exceeded consensus by 17.3%. Management raised full-year Adjusted EPS guidance to $9.75 at the midpoint, citing strong specialty segment demand, successful integration of recent acquisitions including Solaris Health, ADS, ION, and GIA, and operational efficiency improvements. The company expects specialty platforms in autoimmune, urology, and oncology to deliver double-digit growth, though tariff headwinds and integration costs may impact some segments.